Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families

Breast Cancer Research and Treatment

Volumn 123, Issue 2, 2010, Pages 581-585

  Stadler, Zsofia K ^a   Saloustros, Emmanuel ^b   Hansen, Nichole A L ^a   Schluger, Alice E ^a   Kauff, Noah D ^a   Offit, Kenneth ^a   Robson, Mark E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

BRCA; Breast cancer; Founder mutations; Jewish; Rearrangements

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; FOUNDER EFFECT; GENE MUTATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; JEW; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; FOUNDER EFFECT; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JEWS; MALE; MIDDLE AGED; MUTATION; NEW YORK CITY; OVARIAN NEOPLASMS; PEDIGREE; PHENOTYPE; RISK ASSESSMENT; RISK FACTORS;

EID: 77956191564     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0818-y     Document Type: Article

References (37)

1. M Robson K Offit 2007 Management of an inherited predisposition to breast cancer N Engl J Med 357 154 162 10.1056/NEJMcp071286 1:CAS:528: DC%2BD2sXnslSjsbk%3D 17625127
2. Y Miki J Swensen D Shattuck-Eidens, et al.. 1994 A strong candidate for the 17 linked breast and ovarian cancer susceptibility gene BRCA1 Science 266 66 71 10.1126/science.7545954 1:CAS:528:DyaK2MXhtF2ns70%3D 7545954
3. R Wooster G Bignell J Lancaster, et al.. 1995 Identification of the breast cancer susceptibility gene BRCA2 Nature 378 789 792 10.1038/378789a0 1:CAS:528:DyaK28XltFWi 8524414
4. SV Tavtigian J Simard J Rommens, et al.. 1996 The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds Nat Genet 12 333 337 10.1038/ng0396-333 1:CAS:528:DyaK28XhvVSgtbk%3D 8589730
5. D Ford DF Easton M Stratton, et al.. 1998 Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families Am J Hum Genet 62 676 689 10.1086/301749 1:CAS:528:DyaK1MXlvFeh 9497246
6. MC King JH Marks JB Mandell 2003 Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 643 646 10.1126/science. 1088759 1:CAS:528:DC%2BD3sXotlWqt7Y%3D 14576434
7. C Oddoux JP Struewing CM Clayton, et al.. 1996 The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1% Nat Genet 14 188 190 10.1038/ng1096-188 1:CAS:528:DyaK28XmtVKntLg%3D 8841192
8. C Phelan E Kwan E Jack, et al.. 2002 A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families Hum Mutat 20 352 357 10.1002/humu.10123 1:CAS:528:DC%2BD38XptV2nu78%3D 12402332
9. ND Kauff P Perez-Segura ME Robson, et al.. 2002 Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families J Med Genet 39 611 614 10.1136/jmg.39.8.611 1:CAS:528: DC%2BD38XntFSkur0%3D 12161607
10. TS Frank AM Deffenbaugh JE Reid, et al.. 2002 Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals J Clin Oncol 20 1480 1490 10.1200/JCO.20.6.1480 1:CAS:528: DC%2BD38XivFeisbY%3D 11896095
11. N Puget OM Sinilnikova D Stoppa-Lyonnet, et al.. 1999 An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? Am J Hum Genet 64 300 302 10.1086/302211 1:CAS:528:DyaK1MXht1elsL8%3D 9915971
12. A Petrij-Bosch T Peelen M van Vliet, et al.. 1997 BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients Nat Genet 17 341 345 10.1038/ng1197-341 1:CAS:528:DyaK2sXntVSqtLk%3D 9354803
13. S Gad V Caux-Moncoutier S Pagès-Berhouet, et al.. 2002 Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families Oncogene 21 6841 6847 10.1038/sj.onc.1205685 1:CAS:528:DC%2BD38XntFent7c%3D 12360411
14. S Agata A Viel L Della Puppa, et al.. 2006 Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations Genes Chromosomes Cancer 45 791 797 10.1002/gcc.20342 1:CAS:528:DC%2BD28Xotlehur8%3D 16715518
15. SJ Ramus PA Harrington C Pye, et al.. 2007 Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer Hum Mutat 28 1207 1215 10.1002/humu.20599 1:CAS:528:DC%2BD1cXpsl2hsg%3D%3D 17688236
16. AM Woodward TA Davis AG Silva, et al.. 2005 Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families J Med Genet 42 5 e31 10.1136/jmg.2004.027961 1:STN:280:DC%2BD2M3ivFSrug%3D%3D 15863663
17. MD Palma SM Domchek J Stopfer, et al.. 2008 The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families Cancer Res 68 7006 7014 10.1158/0008-5472.CAN-08-0599 18703817
18. M Thomassen AM Gerdes D Cruger, et al.. 2006 Low frequency of large genomic rearrangements of BRCA1 and BRCA2 in western Denmark Cancer Genet Cytogenet 168 168 171 10.1016/j.cancergencyto.2005.12.016 1:CAS:528: DC%2BD28Xmslyktbs%3D 16843109
19. F Casilli I Tournier OM Sinilnikova, et al.. 2006 The contribution of germline rearrangements to the spectrum of BRCA2 mutations J Med Genet 43 e49 10.1136/jmg.2005.040212 1:STN:280:DC%2BD28ris1Wlug%3D%3D 16950820
20. T Wang I Lerer Z Gueta, et al.. 2005 A deletion/insertion mutation in the BRCA2 gene in a breast cancer family: a possible role of the Alu-polyA tail in the evolution of the deletion Genes Chromosomes Cancer 31 91 95 10.1002/gcc.1110 1:CAS:528:DC%2BD2MXhtVejtbjP
21. S Agata M Dalla Palma M Callegaro, et al.. 2005 Large genomic deletions inactivate the BRCA2 gene in breast cancer families J Med Genet 42 e64 10.1136/jmg.2005.032789 1:STN:280:DC%2BD2MrisV2isg%3D%3D 16199546
22. FJ Couch ML DeShano MA Blackwood, et al.. 1997 BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer N Engl J Med 336 1409 1415 10.1056/NEJM199705153362002 1:STN:280:DyaK2s3nsVShuw%3D%3D 9145677
23. D Shattuck-Eidens A Oliphant M McClure, et al.. 1997 BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing JAMA 278 1242 1250 10.1001/jama.278.15.1242 1:CAS:528:DyaK2sXmvFemtLk%3D 9333265
24. T Walsh S Casadei KH Coats, et al.. 2006 Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer JAMA 295 1379 1388 10.1001/jama.295.12.1379 1:CAS:528:DC%2BD28Xislehurs%3D 16551709
25. T Distelman-Menachem T Shapira Y Laitman, et al.. 2009 Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women Fam Cancer 8 127 133 10.1007/s10689-008-9216-6 1:CAS:528:DC%2BD1MXlvV2jtrY%3D 18798010
26. K Offit T Gilewski P McGuire, et al.. 1996 Germline BRCA1 185delAG mutations in Jewish women with breast cancer Lancet 347 1643 1645 10.1016/S0140-6736(96)91484-1 1:STN:280:DyaK283jvVOltw%3D%3D 8642955
27. S Neuhausen T Gilewski L Norton, et al.. 1996 Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer Nat Genet 13 126 128 10.1038/ng0596-126 1:CAS:528:DyaK28XksVWgu70%3D 8673092
28. K Nafa J Angell L Bonavita, et al.. 1999 Direct detection of common mutations in the BRCA1, BRCA2 genes by amplified created restriction enzyme site (ACRES) Am J Hum Genet 65 A58
29. TS Frank SA Manley OI Olopade, et al.. 1998 Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk J Clin Oncol 16 2417 2425 1:CAS:528:DyaK1cXks1Gntbo%3D 9667259
30. National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed 18 December 2009
31. CH Barcenas GM Hosain B Arun, et al.. 2006 Assessing BRCA carrier probabilities in extended families J Clin Oncol 24 354 360 10.1200/JCO.2005.02. 2368 16421416
32. R Shiri-Sverdlov P Oefner L Green, et al.. 2000 Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer Hum Mutat 16 491 501 10.1002/1098-1004(200012)16:6<491:: AID-HUMU6>3.0.CO;2-J 1:CAS:528:DC%2BD3MXhs1ektg%3D%3D 11102978
33. PD Pharoah AC Antoniou DF Easton, et al.. 2008 Polygenes, risk prediction, and targeted prevention of breast cancer N Engl J Med 358 26 2796 2803 10.1056/NEJMsa0708739 1:CAS:528:DC%2BD1cXnvFamt7Y%3D 18579814
34. WD Foulkes 2008 Inherited susceptibility to common cancers N Engl J Med 359 20 2143 2153 10.1056/NEJMra0802968 1:CAS:528:DC%2BD1cXhtlOrtLbJ 19005198
35. Gold B, Kirchhoff T, Stefanov S et al. (2008) Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci USA 105(11):4340-4365. Epub 2008 Mar 7
36. DF Easton KA Pooley AM Dunning, et al.. 2007 Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 7148 1087 1093 10.1038/nature05887 1:CAS:528:DC%2BD2sXmvFKmurc%3D 17529967
37. ME Robson CD Storm J Weitzel, et al.. 2010 American society of clinical oncology policy statement update: genetic and genomic testing for cancer susceptibility J Clin Oncol 28 893 901 10.1200/JCO.2009.27.0660 20065170